| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 766 | 164 | 3.353 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 767 | 164 | 3.353 | 0 | 0 | 9.996 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 14.050 | 9.946 | 9.844 | 2.512 | 1.875 | 10.244 | 163 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -13.283 | -9.782 | -6.491 | -2.512 | -1.875 | -248 | -163 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -13.306 | -9.787 | -6.706 | -2.512 | -1.875 | -518 | -163 | 0 | 0 | 0 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Oftalmo Terapia Liz S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 45.292 | 44.831 | 44.072 | 43.263 | 42.425 | 32.256 | 31.541 | 31.638 | 31.543 | 31.366 |
| Current Assets | 5.804 | 5.205 | 5.576 | 2.904 | 2.273 | 35 | 519 | 59 | 58 | 58 |
| Inventories | 2.791 | 2.688 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.060 | 2.387 | 5.269 | 1.856 | 1.871 | 0 | 460 | 0 | 0 | 0 |
| Cash | 953 | 130 | 307 | 1.048 | 401 | 35 | 58 | 59 | 58 | 58 |
| Shareholders Funds | 35.510 | 25.361 | 18.226 | 15.379 | 13.206 | 12.438 | 11.999 | 12.037 | 12.000 | 11.933 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 15.587 | 24.675 | 31.423 | 30.788 | 31.492 | 19.853 | 20.060 | 19.661 | 19.601 | 19.491 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Oftalmo Terapia Liz S.r.l.